Shanghai Xinhuanhe Pharmaceutical Co., Ltd.

Manufacturing subsidiary of the Chenpon Pharmaceutical group, which acquired it in 2014 along with its own production site. The group works in pharmaceutical development and pulmonary drug delivery technology, with products in digestive, psychiatric, respiratory, cardiovascular, antitumour and surgical analgesia areas, and a 25,000-square-metre commercial plant in Songjiang completed in 2023.